| Date Filed | Type | Description |
| 06/06/2023 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 5,681 options to buy
@ $74.12, valued at
$421.1k
|
|
| 03/06/2023 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 2,082 options to buy
@ $65.32, valued at
$136k
|
|
| 01/13/2023 |
4
| JEFFS ROGER (CEO) has filed a Form 4 on Liquidia Corp|
Txns:
| Granted 289,500 shares
@ $0
Granted 371,154 options to buy
@ $6.17, valued at
$2.3M
|
|
| 01/05/2023 |
4
| JEFFS ROGER (CEO) has filed a Form 4 on Liquidia Corp|
Txns:
| Exercised 15,807 restricted stock units
@ $0 |
|
| 10/04/2022 |
4
| JEFFS ROGER (CEO) has filed a Form 4 on Liquidia Corp|
Txns:
| Exercised 47,423 restricted stock units
@ $0 |
|
| 09/07/2022 |
4
| JEFFS ROGER (CEO) has filed a Form 4 on Liquidia Corp|
Txns:
| Bought 43,820 shares
@ $5.568, valued at
$244k
|
|
| 09/01/2022 |
4
| JEFFS ROGER (CEO) has filed a Form 4 on Liquidia Corp|
Txns:
| Bought 993 shares
@ $4.9045, valued at
$4.9k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 16,976 options to buy
@ $25.53, valued at
$433.4k
|
|
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2022 |
4
| JEFFS ROGER (CEO) has filed a Form 4 on Liquidia Corp|
Txns:
| Granted 154,167 shares
@ $0 |
|
| 03/08/2022 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 2,347 options to buy
@ $29.91, valued at
$70.2k
|
|
| 01/04/2022 |
4
| JEFFS ROGER (CEO) has filed a Form 4 on Liquidia Corp|
Txns:
| Granted 1,682,827 options to buy
@ $5.14, valued at
$8.6M
Granted 63,230 restricted stock units
@ $0 |
|
| 11/23/2021 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Bought 3,950 shares
@ $37.3038, valued at
$147.4k
|
|
| 09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 7,325 options to buy
@ $61.32, valued at
$449.2k
|
|
| 04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2020 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Liquidia Corp|
Txns:
| Acquired 1,387,500 shares
@ $6, valued at
$8.3M
Granted 30,000 options to buy
@ $3.38, valued at
$101.4k
|
|
| 11/19/2020 |
3
| JEFFS ROGER (Director) has filed a Form 3 on Liquidia Corp |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 13,000 options to buy
@ $77.38, valued at
$1M
|
|
| 03/19/2020 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 4,496 options to buy
@ $45.14, valued at
$202.9k
|
|
| 01/14/2020 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Exercised 9,127 options to buy
@ $9, valued at
$82.1k
Exercised 5,193 options to buy
@ $8.02, valued at
$41.6k
Exercised 11,000 options to buy
@ $4.95, valued at
$54.5k
Exercised 34,866 options to buy
@ $12.95, valued at
$451.5k
|
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2019 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Exercised 3,672 options to buy
@ $3.67, valued at
$13.5k
Exercised 39,948 options to buy
@ $2.85, valued at
$113.9k
Exercised 13,000 options to buy
@ $3.45, valued at
$44.9k
|
|
| 07/02/2019 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 1,308 shares
@ $14.17, valued at
$18.5k
|
|
| 06/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2019 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Granted 10,000 options to buy
@ $9.36, valued at
$93.6k
|
|
| 04/17/2019 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axovant Sciences Ltd.|
Txns:
| Granted 255,000 options to buy
@ $1.06, valued at
$270.3k
|
|
| 03/21/2019 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Axsome Therapeutics, Inc.|
Txns:
| Granted 34,866 options to buy
@ $12.95, valued at
$451.5k
|
|
|